Your search returned 3 results.

Results
	1.	The combination of immunosuppression and carrier cells significantly enhances the efficacy of oncolytic poxvirus in the pre-immunized host. [electronic resource] by Guo, Z S Parimi, V O'Malley, M E Thirunavukarasu, P Sathaiah, M Austin, F Bartlett, D L Producer: 20110519 In: Gene therapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Oncolytic poxvirus armed with Fas ligand leads to induction of cellular Fas receptor and selective viral replication in FasR-negative cancer. [electronic resource] by Sathaiah, M Thirunavukkarasu, P O'Malley, M E Kavanagh, M A Ravindranathan, R Austin, F Guo, Z S Bartlett, D L Producer: 20120822 In: Cancer gene therapy vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	TRAIL gene-armed oncolytic poxvirus and oxaliplatin can work synergistically against colorectal cancer. [electronic resource] by Ziauddin, M F Guo, Z S O'Malley, M E Austin, F Popovic, P J Kavanagh, M A Li, J Sathaiah, M Thirunavukarasu, P Fang, B Lee, Y J Bartlett, D L Producer: 20100818 In: Gene therapy vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search